IDEXX Laboratories, Inc. (IDXX) is listed on NASDAQ in Medical Device Stocks. It is $554.74, +1.77%, with a $43.7B market cap. RSI is 47.7, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 47.7 Neutral
Market Cap $43.7B
Volume 250.8K
Fundamentals — 10-Q Q2 2026
Revenue $2.4B
Net Income $616.9M
EPS $7.74
Gross Margin 63.7%
Operating Margin 33.4%
Net Margin 26.2%
Debt / Equity 0.2x
P/E Ratio 71.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Hunt Nimrata | Executive Vice President | Sell | 1,758 | $634.57 | $1.1M | 2026 Mar 3 |
| Mazelsky Jonathan Jay | President and CEO | Sell | 23,326 | $657.55 | $15.3M | 2026 Feb 26 |
| Hunt Nimrata | Executive Vice President | Sell | 2,693 | $661.54 | $1.8M | 2026 Feb 26 |
| Hunt Nimrata | Executive Vice President | Sell | 9,425 | $703.34 | $6.6M | 2025 Nov 7 |
| Szostak M Anne | Director | Sell | 2,187 | $647.33 | $1.4M | 2025 Aug 22 |
| Erickson Michael G | Executive Vice President | Sell | 406 | $649.96 | $263,812 | 2025 Aug 12 |
| Hunt Nimrata | Executive Vice President | Sell | 1,200 | $656.53 | $787,836 | 2025 Aug 11 |
| Underberg Sharon E. | EVP, GC & Corporate Secretary | Sell | 5,450 | $651.60 | $3.6M | 2025 Aug 8 |
| Hunt Nimrata | Executive Vice President | Sell | 7,143 | $630.43 | $4.5M | 2025 Aug 6 |
| Lane Michael | Executive Vice President | Sell | 8,411 | $627.73 | $5.3M | 2025 Aug 6 |
| Mazelsky Jonathan Jay | President and CEO | Sell | 29,260 | $631.98 | $18.5M | 2025 Aug 6 |
| Szostak M Anne | Director | Sell | 2,306 | $512.98 | $1.2M | 2025 May 21 |
| Junius Daniel M | Director | Sell | 2,683 | $506.41 | $1.4M | 2025 May 13 |
| Vandebroek Sophie V. | Director | Sell | 1,279 | $491.34 | $628,424 | 2025 May 9 |
| Fennell George | Executive Vice President | Sell | 9,986 | $462.53 | $4.6M | 2025 Feb 10 |
| Szostak M Anne | Director | Sell | 3,000 | $465.95 | $1.4M | 2025 Feb 7 |
| Vandebroek Sophie V. | Director | Sell | 344 | $420.44 | $144,631 | 2024 Nov 27 |
| Szostak M Anne | Director | Sell | 500 | $469.37 | $234,685 | 2024 Sep 6 |
| Claflin Bruce L. | Director | Sell | 200 | $540.80 | $108,160 | 2024 May 17 |
| Polewaczyk James F | Executive Vice President | Sell | 8,104 | $558.44 | $4.5M | 2024 Mar 6 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $100.74 | 44.7 | $6.6B |
| | $145.15 | 42.3 | $10.1B |
| | $71.72 | 56.2 | $32.6B |
| | $321.58 | 47.0 | $12.7B |
Take IDXX further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put IDXX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when IDEXX Laboratories, Inc. next reports.
Set alerts on IDXX
Get notified when IDEXX Laboratories, Inc. hits your price targets or technical conditions are met.
Get Started Free